Role of oral hypoglycemic therapy in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease

Даминова Л.Т, Садикова Д.Ш, Муминова C.У

Марказий Осиё эндокринологик журнали · 2024-yil

Annotatsiya

For patients with diabetes, one of the main therapeutic goals is to achieve target glycemic levels. In the presence of NAFLD, the attending physician is faced with some restrictions when choosing glucose-lowering therapy. The drugs, in addition to sufficient glucose-lowering activity, must be safe for the liver and not have hepatotoxicity. In addition, glucose-lowering drugs must have proven cardiovascular safety, since type 2 diabetes and NAFLD mutually aggravate not only each other’s course, but also significantly increase cardiovascular risk.

Maqola ma’lumotlari
MualliflarДаминова Л.Т, Садикова Д.Ш, Муминова C.У
JurnalМарказий Осиё эндокринологик журнали
NashriyotРеспублика ихтисослаштирилган эндокринология илмий-амалий тиббиёт маркази
ISSN2181-3426
Nashr sanasi2024-07-04
Jild4
Son1
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-09-07

Maqolaning asl sahifasi

Kalit so‘zlar

сахарный диабет 2 типа, НАЖБП, сахароснижающие препараты, Type 2 diabetes, NAFLD, hypoglycemic drugs, Qandli diabet 2 turi, NAYJK, gipoglikemik preparatlar

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAДаминова Л.Т, Садикова Д.Ш, & Муминова C.У (2024). ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Марказий Осиё эндокринологик журнали, 4(1). https://www.tadqiqot.uz/index.php/cae/article/view/9756
GOST (OAK)Даминова Л.Т, Садикова Д.Ш, Муминова C.У ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE // Марказий Осиё эндокринологик журнали. – 2024. – T. 4, № 1.
MLAДаминова Л.Т, Садикова Д.Ш, and Муминова C.У. “ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.” Марказий Осиё эндокринологик журнали, 4(1), 2024. https://www.tadqiqot.uz/index.php/cae/article/view/9756
ChicagoДаминова Л.Т, Садикова Д.Ш, and Муминова C.У. “ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.” Марказий Осиё эндокринологик журнали, 4(1) (2024). https://www.tadqiqot.uz/index.php/cae/article/view/9756
HarvardДаминова Л.Т, Садикова Д.Ш, and Муминова C.У (2024) ‘ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE’, Марказий Осиё эндокринологик журнали, 4(1). https://www.tadqiqot.uz/index.php/cae/article/view/9756
BibTeX
@article{article2024,
  title = {ROLE OF ORAL HYPOGLYCEMIC THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH NON-ALCOHOLIC FATTY LIVER DISEASE},
  author = {Даминова Л.Т and Садикова Д.Ш and Муминова C.У},
  journal = {Марказий Осиё эндокринологик журнали},
  year = {2024},
  volume = {4},
  number = {1},
  url = {https://www.tadqiqot.uz/index.php/cae/article/view/9756}
}

Boshqa maqola uchun iqtibos tayyorlash

Марказий Осиё эндокринологик журнали jurnalidan boshqa maqolalar

Марказий Осиё эндокринологик журнали — barcha maqolalar · 2024-yil arxivi

Даминова Л.Т — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari